Literature DB >> 11481170

Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease.

F Jessen1, C Kucharski, T Fries, A Papassotiropoulos, K Hoenig, W Maier, R Heun.   

Abstract

OBJECTIVE: Disturbed sensory gating has been related to attention deficit and greater distractibility in patients with schizophrenia, and dysfunction of the alpha-7 subunit of the cholinergic nicotinic receptor has been discussed as its biological basis. Alzheimer's disease is characterized by a cholinergic deficit, and postmortem studies have reported alpha-7 receptor loss in patients with Alzheimer's disease. In this study, the authors tested whether sensory gating is disturbed in patients with Alzheimer's disease.
METHOD: Suppression of the P50 event-related potential following the second click of a double-click paradigm, a measure of sensory gating, was assessed in 17 Alzheimer's disease patients and 17 comparison subjects.
RESULTS: Alzheimer's disease patients showed less P50 suppression following the second click relative to the comparison subjects.
CONCLUSIONS: Disturbed sensory gating might result from cholinergic dysfunction and possibly from alpha-7 nicotinic receptor loss in patients with Alzheimer's disease. Prospective studies should investigate the relationship between sensory gating deficit and behavioral disturbances in Alzheimer's disease patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481170     DOI: 10.1176/appi.ajp.158.8.1319

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

Review 1.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

2.  Towards a functional topography of sensory gating areas: invasive P50 recording and electrical stimulation mapping in epilepsy surgery candidates.

Authors:  Martin Kurthen; Peter Trautner; Timm Rosburg; Thomas Grunwald; Thomas Dietl; Kai-Uwe Kühn; Carlo Schaller; Christian E Elger; Horst Urbach; Kost Elisevich; Nash N Boutros
Journal:  Psychiatry Res       Date:  2007-05-21       Impact factor: 3.222

Review 3.  Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.

Authors:  Karin R Tietje; David J Anderson; R Scott Bitner; Eric A Blomme; Paul J Brackemeyer; Clark A Briggs; Kaitlin E Browman; Dagmar Bury; Peter Curzon; Karla U Drescher; Jennifer M Frost; Ryan M Fryer; Gerard B Fox; Jens Halvard Gronlien; Monika Håkerud; Earl J Gubbins; Sabine Halm; Richard Harris; Rosalind J Helfrich; Kathy L Kohlhaas; Devalina Law; John Malysz; Kennan C Marsh; Ruth L Martin; Michael D Meyer; Angela L Molesky; Arthur L Nikkel; Stephani Otte; Liping Pan; Pamela S Puttfarcken; Richard J Radek; Holly M Robb; Eva Spies; Kirsten Thorin-Hagene; Jeffrey F Waring; Hilde Ween; Hongyu Xu; Murali Gopalakrishnan; William H Bunnelle
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.

Authors:  Dominik Feuerbach; Nicole Pezous; Markus Weiss; Kasra Shakeri-Nejad; Kurt Lingenhoehl; Daniel Hoyer; Konstanze Hurth; Graeme Bilbe; Christopher R Pryce; Kevin McAllister; Frederique Chaperon; Klaus Kucher; Donald Johns; Thomas Blaettler; Cristina Lopez Lopez
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

5.  Children with Cerebral Palsy Hyper-Gate Somatosensory Stimulations of the Foot.

Authors:  Max J Kurz; Alex I Wiesman; Nathan M Coolidge; Tony W Wilson
Journal:  Cereb Cortex       Date:  2018-07-01       Impact factor: 5.357

6.  A reduced somatosensory gating response in individuals with multiple sclerosis is related to walking impairment.

Authors:  David J Arpin; James E Gehringer; Tony W Wilson; Max J Kurz
Journal:  J Neurophysiol       Date:  2017-07-19       Impact factor: 2.714

Review 7.  Sensory gating: a translational effort from basic to clinical science.

Authors:  Howard C Cromwell; Ryan P Mears; Li Wan; Nash N Boutros
Journal:  Clin EEG Neurosci       Date:  2008-04       Impact factor: 1.843

Review 8.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

9.  P50 sensory gating is related to performance on select tasks of cognitive inhibition.

Authors:  Carly A Yadon; Julie M Bugg; Michael A Kisley; Deana B Davalos
Journal:  Cogn Affect Behav Neurosci       Date:  2009-12       Impact factor: 3.282

10.  A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice.

Authors:  M J Gandal; R S Ehrlichman; N D Rudnick; S J Siegel
Journal:  Neuroscience       Date:  2008-09-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.